South America ECMO Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality (Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates)
The South America ECMO market is expected to grow from US$ 53.00 million in 2022 to US$ 60.58 million by 2028. It is estimated to record a CAGR of 2.3% from 2022 to 2028.
Growing Adoption of ECMO in Lung Transplantation Procedures Bolsters South America ECMO Market Growth
Lung transplantation is a life-saving treatment option for patients suffering from end-stage lung diseases, such as COPD, Idiopathic pulmonary fibrosis (IPF), and cystic fibrosis, to improve the quality of life. ECMO is a versatile tool used in all lung transplantation phases, such as preoperative, intraoperative, and postoperative periods. It acts as a bridge in patient undergoing lung transplantation. Therefore, the adoption of ECMO during lung transplantation is growing rapidly to manage patients with life-threatening lung disease. Primary graft dysfunction (PGD) is the leading cause of death after a lung transplant. Thus, ECMO is used penultimately in treating PGD post lung transplantation. Thus, the demand for ECMO equipment is growing for treating the patients suffering from PGD.
South America ECMO Market Overview
The SAM ECMO market is segmented into Brazil, Argentina, and the Rest of SAM. Brazil dominated the market in 2022. According to World Heart Federation, noncommunicable diseases such as cardiovascular disease accounts for 74% of total deaths in Brazil. According to Global Burden Study (GBD) and Brazilian Unified Health System, cardiovascular disease was the leading cause of death in Brazil in 2019. Due to the increasing aging population in Brazil, the prevalence of cardiovascular diseases is increasing each year. According to GBD, the number of ischemic heart disease (IHD) cases reached 4 million in 2019. Further, about 171,246 deaths were reported due to IHD, which accounted for 43% of cardiovascular deaths and 12% of total deaths in Brazil in 2019. Thus, growing cardiovascular disease cases in Brazil are driving the ECMO market growth in the country.
South America ECMO Market Revenue and Forecast to 2028 (US$ Million)
South America ECMO Market Segmentation
The South America ECMO market is segmented based on modality, application, age group, and country.
Based on modality, the SAM ECMO market is segmented into venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The venoarterial ECMO segment held the largest market share in 2022.
Based on application, the SAM ECMO market is bifurcated into respiratory and cardiology. The respiratory segment held a larger market share in 2022.
Based on age group, the SAM ECMO market is segmented into adults, pediatrics, and neonates. The adults segment held the largest market share in 2022.
Based on country, the SAM ECMO market has been categorized into Brazil, Argentina, and the Rest of SAM. Our regional analysis states that Brazil dominated the market in 2022.
ABIOMED Inc, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation, and Terumo Group are the leading companies operating in the SAM ECMO market.
Growing Adoption of ECMO in Lung Transplantation Procedures Bolsters South America ECMO Market Growth
Lung transplantation is a life-saving treatment option for patients suffering from end-stage lung diseases, such as COPD, Idiopathic pulmonary fibrosis (IPF), and cystic fibrosis, to improve the quality of life. ECMO is a versatile tool used in all lung transplantation phases, such as preoperative, intraoperative, and postoperative periods. It acts as a bridge in patient undergoing lung transplantation. Therefore, the adoption of ECMO during lung transplantation is growing rapidly to manage patients with life-threatening lung disease. Primary graft dysfunction (PGD) is the leading cause of death after a lung transplant. Thus, ECMO is used penultimately in treating PGD post lung transplantation. Thus, the demand for ECMO equipment is growing for treating the patients suffering from PGD.
South America ECMO Market Overview
The SAM ECMO market is segmented into Brazil, Argentina, and the Rest of SAM. Brazil dominated the market in 2022. According to World Heart Federation, noncommunicable diseases such as cardiovascular disease accounts for 74% of total deaths in Brazil. According to Global Burden Study (GBD) and Brazilian Unified Health System, cardiovascular disease was the leading cause of death in Brazil in 2019. Due to the increasing aging population in Brazil, the prevalence of cardiovascular diseases is increasing each year. According to GBD, the number of ischemic heart disease (IHD) cases reached 4 million in 2019. Further, about 171,246 deaths were reported due to IHD, which accounted for 43% of cardiovascular deaths and 12% of total deaths in Brazil in 2019. Thus, growing cardiovascular disease cases in Brazil are driving the ECMO market growth in the country.
South America ECMO Market Revenue and Forecast to 2028 (US$ Million)
South America ECMO Market Segmentation
The South America ECMO market is segmented based on modality, application, age group, and country.
Based on modality, the SAM ECMO market is segmented into venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The venoarterial ECMO segment held the largest market share in 2022.
Based on application, the SAM ECMO market is bifurcated into respiratory and cardiology. The respiratory segment held a larger market share in 2022.
Based on age group, the SAM ECMO market is segmented into adults, pediatrics, and neonates. The adults segment held the largest market share in 2022.
Based on country, the SAM ECMO market has been categorized into Brazil, Argentina, and the Rest of SAM. Our regional analysis states that Brazil dominated the market in 2022.
ABIOMED Inc, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation, and Terumo Group are the leading companies operating in the SAM ECMO market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM ECMO Market – By Modality
1.3.2 SAM ECMO Market – By Application
1.3.3 SAM ECMO Market – By Age Group
1.3.4 SAM ECMO Market – By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM ECMO MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM ECMO MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures
5.1.2 Growing Adoption of ECMO in Lung Transplantation Procedures
5.2 Market Restraints
5.2.1 Complications Associated with ECMO
5.3 Market Opportunities
5.3.1 Increasing Survival Rates with ECMO
5.4 Future Trends
5.4.1 Surging Product Developments and Approvals
5.5 Impact Analysis
6. ECMO MARKET – SAM ANALYSIS
6.1 SAM ECMO Market Revenue Forecast & Analysis
7. SAM ECMO MARKET ANALYSIS – BY MODALITY
7.1 Overview
7.2 SAM ECMO Market Share by Modality 2021 & 2028 (%)
7.3 Venoarterial ECMO
7.3.1 Overview
7.3.2 Venoarterial ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
7.4 Venovenous ECMO
7.4.1 Overview
7.4.2 Venovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
7.5 Arteriovenous ECMO
7.5.1 Overview
7.5.2 Arteriovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
8. SAM ECMO MARKET ANALYSIS – BY APPLICATION
8.1 Overview
8.2 SAM ECMO Market, By Application 2021 & 2028 (%)
8.4 Respiratory
8.4.1 Overview
8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Cardiology
8.5.1 Overview
8.5.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)
9. SAM ECMO MARKET ANALYSIS – BY AGE GROUP
9.1 Overview
9.2 SAM ECMO Market, By Age Group 2021 & 2028 (%)
9.3 Adults
9.3.1 Overview
9.3.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Pediatrics
9.4.1 Overview
9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Neonates
9.5.1 Overview
9.5.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)
10. SAM ECMO MARKET – COUNTRY ANALYSIS
10.1 Overview
10.1.1 SAM: ECMO, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: ECMO, by Modality, 2019-2028 (US$ Million)
10.1.1.1.4 Brazil: ECMO, by Application, 2019-2028 (US$ Million)
10.1.1.1.5 Brazil: ECMO, by Age Group, 2019-2028 (US$ Million)
10.1.1.2 Argentina: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: ECMO, by Modality, 2019-2028 (US$ Million)
10.1.1.2.4 Argentina: ECMO, by Application, 2019-2028 (US$ Million)
10.1.1.2.5 Argentina: ECMO, by Age Group, 2019-2028 (US$ Million)
10.1.1.3 Rest of SAM: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of SAM: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of SAM: ECMO, by Modality, 2019-2028 (US$ Million)
10.1.1.3.4 Rest of SAM: ECMO, by Application, 2019-2028 (US$ Million)
10.1.1.3.5 Rest of SAM: ECMO, by Age Group, 2019-2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 Terumo Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MicroPort Scientific Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nipro Medical Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Getinge AB
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Braile Biomedica
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Fresenius Medical Care AG & Co KGaA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 ABIOMED Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM ECMO Market – By Modality
1.3.2 SAM ECMO Market – By Application
1.3.3 SAM ECMO Market – By Age Group
1.3.4 SAM ECMO Market – By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM ECMO MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM ECMO MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures
5.1.2 Growing Adoption of ECMO in Lung Transplantation Procedures
5.2 Market Restraints
5.2.1 Complications Associated with ECMO
5.3 Market Opportunities
5.3.1 Increasing Survival Rates with ECMO
5.4 Future Trends
5.4.1 Surging Product Developments and Approvals
5.5 Impact Analysis
6. ECMO MARKET – SAM ANALYSIS
6.1 SAM ECMO Market Revenue Forecast & Analysis
7. SAM ECMO MARKET ANALYSIS – BY MODALITY
7.1 Overview
7.2 SAM ECMO Market Share by Modality 2021 & 2028 (%)
7.3 Venoarterial ECMO
7.3.1 Overview
7.3.2 Venoarterial ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
7.4 Venovenous ECMO
7.4.1 Overview
7.4.2 Venovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
7.5 Arteriovenous ECMO
7.5.1 Overview
7.5.2 Arteriovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
8. SAM ECMO MARKET ANALYSIS – BY APPLICATION
8.1 Overview
8.2 SAM ECMO Market, By Application 2021 & 2028 (%)
8.4 Respiratory
8.4.1 Overview
8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Cardiology
8.5.1 Overview
8.5.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)
9. SAM ECMO MARKET ANALYSIS – BY AGE GROUP
9.1 Overview
9.2 SAM ECMO Market, By Age Group 2021 & 2028 (%)
9.3 Adults
9.3.1 Overview
9.3.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Pediatrics
9.4.1 Overview
9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Neonates
9.5.1 Overview
9.5.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)
10. SAM ECMO MARKET – COUNTRY ANALYSIS
10.1 Overview
10.1.1 SAM: ECMO, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: ECMO, by Modality, 2019-2028 (US$ Million)
10.1.1.1.4 Brazil: ECMO, by Application, 2019-2028 (US$ Million)
10.1.1.1.5 Brazil: ECMO, by Age Group, 2019-2028 (US$ Million)
10.1.1.2 Argentina: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: ECMO, by Modality, 2019-2028 (US$ Million)
10.1.1.2.4 Argentina: ECMO, by Application, 2019-2028 (US$ Million)
10.1.1.2.5 Argentina: ECMO, by Age Group, 2019-2028 (US$ Million)
10.1.1.3 Rest of SAM: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of SAM: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of SAM: ECMO, by Modality, 2019-2028 (US$ Million)
10.1.1.3.4 Rest of SAM: ECMO, by Application, 2019-2028 (US$ Million)
10.1.1.3.5 Rest of SAM: ECMO, by Age Group, 2019-2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 Terumo Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MicroPort Scientific Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nipro Medical Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Getinge AB
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Braile Biomedica
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Fresenius Medical Care AG & Co KGaA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 ABIOMED Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. SAM ECMO Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil ECMO Market, by Modality – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil ECMO Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil ECMO Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina ECMO Market, by Modality – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina ECMO Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina ECMO Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of SAM ECMO Market, by Modality – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of SAM ECMO Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of SAM ECMO Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 11. Recent Inorganic Growth Strategies
Table 12. Recent Organic Growth Strategies
Table 13. Glossary of Terms
Table 1. SAM ECMO Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil ECMO Market, by Modality – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil ECMO Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil ECMO Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina ECMO Market, by Modality – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina ECMO Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina ECMO Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of SAM ECMO Market, by Modality – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of SAM ECMO Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of SAM ECMO Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 11. Recent Inorganic Growth Strategies
Table 12. Recent Organic Growth Strategies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. SAM ECMO Market Segmentation
Figure 2. SAM ECMO Market, By Country
Figure 3. SAM ECMO Market Overview
Figure 4. SAM ECMO Market, By Modality
Figure 5. SAM ECMO Market, By Country
Figure 7. SAM: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis: SAM ECMO Market
Figure 10. SAM ECMO Market – Revenue Forecast and Analysis
Figure 11. SAM ECMO Market Share by Modality 2021 & 2028 (%)
Figure 12. Venoarterial ECMO: SAM ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 13. Venovenous ECMO: SAM ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 14. Arteriovenous ECMO: SAM ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 15. SAM ECMO Market, by Application 2021 & 2028 (%)
Figure 16. Respiratory : SAM ECMO Market Revenue and Forecasts To 2028 (US$ MN)
Figure 17. Cardiology : SAM ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. SAM ECMO Market, by Age Group 2021 & 2028 (%)
Figure 19. Adults : SAM ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Pediatrics : SAM ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Neonates : SAM ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. SAM: ECMO Market, by Key Country – Revenue (2021) (US$ Million)
Figure 23. SAM: ECMO, by Country, 2021 & 2028 (%)
Figure 24. Brazil: ECMO – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Argentina: ECMO – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rest of SAM: ECMO – Revenue and Forecast to 2028 (US$ Million)
Figure 1. SAM ECMO Market Segmentation
Figure 2. SAM ECMO Market, By Country
Figure 3. SAM ECMO Market Overview
Figure 4. SAM ECMO Market, By Modality
Figure 5. SAM ECMO Market, By Country
Figure 7. SAM: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis: SAM ECMO Market
Figure 10. SAM ECMO Market – Revenue Forecast and Analysis
Figure 11. SAM ECMO Market Share by Modality 2021 & 2028 (%)
Figure 12. Venoarterial ECMO: SAM ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 13. Venovenous ECMO: SAM ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 14. Arteriovenous ECMO: SAM ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 15. SAM ECMO Market, by Application 2021 & 2028 (%)
Figure 16. Respiratory : SAM ECMO Market Revenue and Forecasts To 2028 (US$ MN)
Figure 17. Cardiology : SAM ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. SAM ECMO Market, by Age Group 2021 & 2028 (%)
Figure 19. Adults : SAM ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Pediatrics : SAM ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Neonates : SAM ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. SAM: ECMO Market, by Key Country – Revenue (2021) (US$ Million)
Figure 23. SAM: ECMO, by Country, 2021 & 2028 (%)
Figure 24. Brazil: ECMO – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Argentina: ECMO – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rest of SAM: ECMO – Revenue and Forecast to 2028 (US$ Million)
